Bermuda Tech Week 2019 to Celebrate Innovation and Explore Opportunities for Growth
20.8.2019 17:27:00 EEST | Business Wire | Press release
Registration is under way and filling fast for Bermuda Tech Week 2019 which will take place at the Hamilton Princess & Beach Club from October 14-18, 2019.
The programme of insightful and engaging events will explore future opportunities and challenges presented by emerging technologies such as artificial intelligence, blockchain, digital assets, insurtech and virtual reality. It will showcase Bermuda’s ongoing success in creating a welcoming, stable and well-regulated environment where technology and start-up companies can thrive.
“Bermuda has a long history of innovation so we understand and recognise the power of technology to positively impact both the economy and society,” said Bermuda Premier David Burt. “Over the past two years, we have built on our strength as a global leader in regulating the risks associated with the global insurance industry to develop a clear regulatory framework around managing the risks associated with Fintech. Our progressive approach has drawn accolades in U.S. Senate hearings and from an SEC commissioner in providing the kind of guidance, oversight and clarity needed for the industry to deliver on its mission to make financial services more accessible to people around the globe. Being at the forefront of innovation will help drive economic growth and job creation so we remain committed to being at the forefront of emerging trends, which is why we look forward to hosting Bermuda Tech Week 2019 in October.”
Andy Burrows, CEO of the Bermuda Business Development Agency (BDA), said: “Bermuda Tech Week 2019 comes at an ideal time and builds on the momentum we have seen in the market, driven by new and innovative legislation. Industry, government and regulatory authorities here in Bermuda work closely together to deliver an environment that facilitates progress. This is reflected in the programme of events that our team has put together. Our aim is for all attendees to come away with a better knowledge of how new technologies can be deployed to drive efficiencies in business and, importantly, what Bermuda has to offer the global market as a domicile of choice for tech companies and start-ups.”
At the heart of Bermuda Tech Week 2019 is the Bermuda Tech Summit which will take place on Wednesday, October 16 under the theme ‘Focused on the Future’. Bermuda’s Premier, David Burt, is set to deliver an opening address. Hosted by the BDA, in partnership with FinTech Bermuda, the all-day summit is free to attend and will explore the transformational impact of technology on investment and business models in a wide range of industry sectors relevant to Bermuda, from hospitality and financial services to telecommunications and insurance. Attendees will gain an in-depth understanding of how Bermuda’s business environment is facilitating innovation.
Events throughout the week will feature an array of speakers and attendees from across Bermuda’s government, industry and regulatory authorities along with some of the world’s most dynamic technology companies, including BitMEX, Blade, ChainThat, Circle, Data Innovation Labs, Flyt, Muckr.ai, SeaHeal, The Giving Block, Uulala, X and XBTO. Leading hotel brands AccorHotels (Fairmont), Hilton, Marriott International and Wyndham Hotel Group will also participate.
The schedule for Bermuda Tech Week 2019 includes:
- Liquidity Summit – a fintech event focused on leading and emerging trends across the world of finance. Presented by Hub Culture and the Ven digital currency, this event will take place on Monday, October 14 and Tuesday, October 15
- Defend and Detect – a technology and technique event hosted by KPMG Bermuda showcasing how technology and business ideas can come together to solve complex challenges in managing regulatory risk and compliance. This event is invitation-only and will take place on Tuesday, October 15
- Hello World – the world’s first AI to AI event hosted by Zeke.ai, Hub Culture’s emergent intelligent machine. This event will take place on Thursday, October 17
- Tech Beach ‘FinTech Innovation Island’ – coming to Bermuda for the first time, this will be an innovative space to explore opportunities for collaboration. Presented by Tech Beach, in partnership with the BDA and the Bermuda Tourism Authority (BTA), this event will be held on Thursday, October 17 and Friday, October 18
To register for events, visit www.bermudatechweek.bm, or if your company is interested in sponsoring or hosting additional events throughout the week, contact bermudatechweek@bda.bm. For a limited period only, take advantage of the $250/night preferred room rate at the Hamilton Princess & Beach Club by clicking here.
CONNECTING BUSINESS
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190820005544/en/
Contact information
Nicola Stevens
nstevens@bda.bm
+1 441 292 7774
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom